Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Terminated × Heparin × Clear all

Phase

Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Plasma Cell 1 Multiple Myeloma 1

Interventions

pembrolizumab 59 Cyclophosphamide 52 Carboplatin 51 Paclitaxel 43 Nivolumab 40 Cisplatin 39 Gemcitabine 36 Dexamethasone 34 Radiotherapy 30 Capecitabine 29 Rituximab 25 Docetaxel 25 fludarabine 24 Bevacizumab 24 venetoclax 21 avelumab 21 Cytarabine 20 atezolizumab 19 Trastuzumab 19 Temozolomide 19 Oxaliplatin 19 Fluorouracil 19 Cetuximab 19 130-nm albumin-bound paclitaxel 19 fludarabine phosphate 18 Pemetrexed 18 Lenalidomide 18 Filgrastim 18 Bortezomib 18 Azacitidine 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00790842 2018-10-24

PrE1003

PrECOG, LLC.

Phase 1/2 Terminated

63 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡